SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,610.00    24.00 (0.52%)
Bid:
4,606.00
Ask:
4,610.00
Spread: 4.00 (0.087%)
Market Cap: £16.80b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Holding(s) in Company

27 Dec 2023 07:04

RNS Number : 8353X
Coca-Cola HBC AG
27 December 2023

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

CH0198251305

Issuer Name

COCA-COLA HBC AG

UK or Non-UK Issuer

Non-UK

2. Reason for Notification

An event changing the breakdown of voting rights

3. Details of person subject to the notification obligation

Name

Truad Verwaltungs A.G.

City of registered office (if applicable)

Zurich

Country of registered office (if applicable)

Switzerland

4. Details of the shareholder

Name

City of registered office

Country of registered office

Kar-Tess Holding

Boval Sarl

Boval Limited

Lavonos Ltd

Torval Investment Corp.

5. Date on which the threshold was crossed or reached

22-Dec-2023

6. Date on which Issuer notified

22-Dec-2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

23.300000

0.000000

23.300000

85355019

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

CH0198251305

85355019

23.300000

Sub Total 8.A

85355019

23.300000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Truad Verwaltungs A.G.

Torval Investment Corp.

23.300000

23.300000%

Truad Verwaltungs A.G.

Boval Limited

23.300000

23.300000%

Truad Verwaltungs A.G.

Kar-Tess Holding

23.300000

23.300000%

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

This notification is made by Truad Verwaltungs A.G. ("Truad") in its capacity as a professional trustee of a private irrevocable discretionary trust established for the primary benefit of descendants of the father of the late Anastasios Georgios Leventis (the "Trust").Up to 22.12.2023 Truad indirectly held in its above capacity through the chain of companies it fully controlled (namely Torval Investment Corp. which controlled its 100% subsidiary Lavonos Ltd. which controlled its 100% subsidiary Boval Limited which controlled its 100% subsidiary Boval S.à.r.l. which controlled its 100% subsidiary Kar-Tess Holding) 23.3% of the total number of the voting rights of the issuer (corresponding to 85,355,019 voting rights and equal number of ordinary shares). On 22.12.2023 (a) Lavonos Ltd. transferred to Torval Investment Corp. the entirety (100%) of the shares it held in the share capital of its subsidiary Boval Limited and (b) a reverse merger was completed in the context of which Boval S.à.r.l. has been absorbed by its direct and wholly (100%) owned subsidiary Kar-Tess Holding. As a result Boval S.à.r.l. ceased to exist and all its assets and liabilities have been universally transferred to Kar-Tess Holding.Following the completion of the aforementioned actions, the percentage of voting rights held indirectly by Truad in the issuer remains unchanged. Truad indirectly holds 23.3% of the total number of the voting rights of the issuer (corresponding to 85,355,019 voting rights and equal number of ordinary shares) through the chain of companies it fully controls (namely Torval Investment Corp. which controls its 100% subsidiary Boval Limited which controls its 100% subsidiary Kar-Tess Holding).Furthermore, Truad controls and exercises the aforementioned voting rights at its discretion without receiving any specific directions or instructions by the beneficiaries of the Trust or any other person and there is no other person who controls Truad.

12. Date of Completion

22-Dec-2023

13. Place Of Completion

Athens, Greece

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
HOLGZMZZKZMGFZM
Date   Source Headline
22nd May 20263:30 pmRNSDirector/PDMR Shareholding
19th May 20263:15 pmRNSDirector/PDMR Shareholding
11th May 20269:00 amRNSDirector Declaration
8th May 20263:15 pmRNSComposition of the Board Committees
8th May 20263:10 pmRNSResult of AGM
7th May 20267:00 amRNSStrong volume drives Q1 sales growth
20th Apr 20263:15 pmRNSDirector/PDMR Shareholding
14th Apr 202612:15 pmRNSNotice of Results
2nd Apr 20267:00 amRNSNotice of AGM, changes to the BoD, dividend dates
1st Apr 20269:15 amRNSTransfer of treasury shares & total voting rights
31st Mar 202611:00 amRNSPublication of Final Terms
27th Mar 20262:45 pmRNSDirector/PDMR Shareholding
27th Mar 20262:15 pmRNSDirector/PDMR Shareholding
26th Mar 20266:18 pmRNSPricing of Issue of Notes
26th Mar 20269:05 amRNSLaunch of Issue of Notes
25th Mar 20261:36 pmRNSPublication of a Prospectus
20th Mar 202611:00 amRNSAnnual Financial Report
19th Mar 20264:55 pmRNSDirector/PDMR Shareholding
19th Mar 20264:45 pmRNSDirector/PDMR Shareholding
18th Mar 20264:15 pmRNSDirector/PDMR Shareholding
18th Mar 202611:35 amRNSDirector/PDMR Shareholding
26th Feb 202611:30 amRNSDirector/PDMR Shareholding
25th Feb 20269:20 amRNSDirector/PDMR Shareholding
24th Feb 20264:55 pmRNSDirector/PDMR Shareholding
24th Feb 20264:50 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:40 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:35 pmRNSDirector/PDMR Shareholding
18th Feb 20264:50 pmRNSDirector/PDMR Shareholding
18th Feb 20264:45 pmRNSDirector/PDMR Shareholding
18th Feb 20264:00 pmRNSDirector/PDMR Shareholding
17th Feb 20263:35 pmRNSDirector/PDMR Shareholding
17th Feb 20263:30 pmRNSDirector/PDMR Shareholding
16th Feb 20262:40 pmRNSDirector/PDMR Shareholding
16th Feb 20262:35 pmRNSDirector/PDMR Shareholding
13th Feb 202610:30 amRNSDirector/PDMR Shareholding
12th Feb 20263:45 pmRNSDirector/PDMR Shareholding
12th Feb 20261:15 pmRNSDirector/PDMR Shareholding
10th Feb 20267:00 amRNSStrong execution and financial performance in 2025
2nd Feb 202610:00 amRNSTransfer of treasury shares & total voting rights
19th Jan 20264:00 pmRNSDirector/PDMR Shareholding
19th Jan 20262:20 pmRNSResult of Extraordinary General Meeting
13th Jan 202611:00 amRNSNotice of Results
5th Jan 202610:00 amRNSDirector/PDMR Shareholding
23rd Dec 20252:45 pmRNSDirector/PDMR Shareholding
23rd Dec 20252:45 pmRNSDirector/PDMR Shareholding
22nd Dec 20252:15 pmRNSDirector/PDMR Shareholding
22nd Dec 20252:15 pmRNSDirector/PDMR Shareholding
18th Dec 20255:00 pmRNSDirector/PDMR Shareholding
18th Dec 20255:00 pmRNSDirector/PDMR Shareholding
18th Dec 20253:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.